Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Exploring avibactam and relebactam inhibition of Klebsiella pneumoniae carbapenemase D179N variant: role of the Ω loop-held deacylation water

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.00350-23Source: DataRank Database

Exploring avibactam and relebactam inhibition of Klebsiella pneumoniae carbapenemase D179N variant: role of the Ω loop-held deacylation water is a research paper published in Antimicrobial Agents and Chemotherapy (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.87)OA: greenTopics (30)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

S. L. Viviani,Krisztina M. Papp‐Wallace ORCID,Robert A. Bonomo ORCID,Focco van den Akker ORCID,T. A. Alsenani

Live enrichment

PubMed:37750722 PMC:PMC10583681 OpenAlex:https://openalex.org/W4387033106

Merck

Grant: MISP 57394

U.S. Department of Veterans Affairs

Grant: 1I01BX001974

BLRD VA

Grant: I01 BX001974

FWCI

0.87

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

2026

greenLicense: https://doi.org/10.1128/ASMCopyrightv2

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10583681/pdf/aac.00350-23.pdf

publisherhttps://journals.asm.org/doi/pdf/10.1128/aac.00350-23

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10583681

journalhttps://doi.org/10.1128/aac.00350-23

Fields of Study

Antibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyCancer therapeutics and mechanisms

MeSH Terms

Anti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCeftazidimeDrug CombinationsIminesKlebsiella pneumoniaeMicrobial Sensitivity TestsWaterCarbapenemsAzabicyclo Compoundsbeta-Lactamase Inhibitors

Keywords

AvibactamKlebsiella pneumoniaeCeftazidime/avibactamBiologyMicrobiologyCeftazidimeChemistryEscherichia coliBacteriaGeneticsPseudomonas aeruginosaProtein crystallographyAntibiotic ResistanceΒ-lactamaseΒ-lactamase Inhibitor

Sustainable Development Goals

SDG 0: Clean water and sanitation

Exploring avibactam and relebactam inhibition of Klebsiella pneumoniae carbapenemase D179N variant: role of the Ω loop-held deacylation water

FAIR Checklist

Authors (5)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)